Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-02-26 01:36 |
Form 20-F for 2020
|
English | 36.0 KB | ||
| 2021-02-25 15:04 |
Reports Fourth Quarter and
Full Year 2020 Results, Announces Data Update from
…
|
English | 166.5 KB | ||
| 2021-02-25 15:04 |
Reports Fourth Quarter and
Full Year 2020 Results, Announces Data Update from
…
|
English | 35.9 KB | ||
| 2021-02-22 15:04 |
Amendment No. 2 to the Master Clinical Trial Collaboration Agreement between th…
|
English | 92.4 KB | ||
| 2021-02-22 15:04 |
Amendment No. 2 to the Master Clinical Trial Collaboration Agreement between th…
|
English | 35.9 KB | ||
| 2021-02-16 15:10 |
Compugen to Release Fourth Quarter and Full Year 2020 Results
on Thursday, Feb…
|
English | 85.1 KB | ||
| 2021-02-16 15:10 |
Compugen to Release Fourth Quarter and Full Year 2020 Results
on Thursday, Feb…
|
English | 35.9 KB | ||
| 2020-12-23 14:59 |
Announces First Development Milestone in License
Agreement with AstraZeneca fo…
|
English | 139.7 KB | ||
| 2020-12-23 14:59 |
Announces First Development Milestone in License
Agreement with AstraZeneca fo…
|
English | 35.9 KB | ||
| 2020-12-11 00:09 |
The Board of Directors of approved 2021 Employee Share Purchase Plan
|
English | 127.2 KB | ||
| 2020-12-11 00:09 |
The Board of Directors of approved 2021 Employee Share Purchase Plan
|
English | 35.7 KB | ||
| 2020-12-11 00:04 |
FORM S-8- REGISTRATION STATEMENT
|
English | 202.6 KB | ||
| 2020-12-11 00:04 |
FORM S-8- REGISTRATION STATEMENT
|
English | 35.8 KB | ||
| 2020-11-05 15:04 |
Reports Third Quarter 2020 Results
|
English | 153.4 KB | ||
| 2020-11-05 15:04 |
Reports Third Quarter 2020 Results
|
English | 36.0 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
